Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines

Abstract excerpt

BACKGROUND: Colorectal cancer (CRC) is a heterogeneous and biologically poorly understood disease. To tailor CRC treatment, it is essential to first model this heterogeneity by defining subtypes of patients with homogeneous biological and clinical characteristics and second match these subtypes to cell lines for which extensive pharmacological data is available, thus linking targeted therapies to patients most...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Colorectal Cancer Surgical Treatments
• Share to Colorectal Cancer Treatments and Studies
• Share to Genetic factors in colorectal cancer